Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laszlo Czirjak

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Annals of the Rheumatic Diseases|October 15, 2013
Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?Ulf Müller-Ladner, Alan Tyndall, Laszlo Czirjak, et al.
Molecular Biology Reports|October 12, 2012
Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn's disease and ankylosing spondylitisMelinda Szabo, Eniko Safrany, Borbala Pazar, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 17, 2009
Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patientsEniko Safrany, Renata Hobor, Laszlo Jakab, et al.
Rheumatology International|November 27, 2008
Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjectsBernadett Farago, Gabor C Talian, Katalin Komlosi, et al.
Annals of the Rheumatic Diseases|May 23, 2012
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group databaseFlorian M P Meier, Klaus W Frommer, Robert Dinser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2015
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary studyKatalin T Kovacs, Sudhakar Reddy Kalluri, Antonio Boza-Serrano, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target in systemic lupus erythematosus: where are we today?Marta Mosca, Dimitrios T Boumpas, Ian N Bruce, et al.
Annals of the Rheumatic Diseases|August 29, 2014
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective studyJérôme Avouac, Ulrich A Walker, Eric Hachulla, et al.
Rheumatology (Oxford, England)|August 16, 2014
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standardsDinesh Khanna, Daniel E Furst, Yannick Allanore, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Annals of the Rheumatic Diseases|October 15, 2013
Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?Ulf Müller-Ladner, Alan Tyndall, Laszlo Czirjak, et al.
Molecular Biology Reports|October 12, 2012
Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn's disease and ankylosing spondylitisMelinda Szabo, Eniko Safrany, Borbala Pazar, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 17, 2009
Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patientsEniko Safrany, Renata Hobor, Laszlo Jakab, et al.
Rheumatology International|November 27, 2008
Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjectsBernadett Farago, Gabor C Talian, Katalin Komlosi, et al.
Annals of the Rheumatic Diseases|May 23, 2012
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group databaseFlorian M P Meier, Klaus W Frommer, Robert Dinser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2015
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary studyKatalin T Kovacs, Sudhakar Reddy Kalluri, Antonio Boza-Serrano, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target in systemic lupus erythematosus: where are we today?Marta Mosca, Dimitrios T Boumpas, Ian N Bruce, et al.
Annals of the Rheumatic Diseases|August 29, 2014
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective studyJérôme Avouac, Ulrich A Walker, Eric Hachulla, et al.
Rheumatology (Oxford, England)|August 16, 2014
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standardsDinesh Khanna, Daniel E Furst, Yannick Allanore, et al.
Pageof 2